Agency Information Collection Activities: Submission for OMB Review; Comment Request, 42957-42959 [2013-17317]
Download as PDF
42957
Federal Register / Vol. 78, No. 138 / Thursday, July 18, 2013 / Notices
resistance. This worrisome trend
prompted CDC to again update
treatment recommendations and no
longer recommend the use of cefixime
as first-line treatment for gonococcal
infections.
Under the GISP protocol, each of the
30 clinics submit an average of 20
isolates per clinic per month (i.e., 240
times per year) recorded on Form 1:
Demographic/Clinical Data. The
estimated time for clinical personnel to
abstract data for Form 1: Demographic/
Clinical Data is 11 minutes per
response.
Each of the five Regional laboratories
receives and processes approximately
20 isolates from each referring clinic per
month (i.e., 121 isolates per regional
laboratory per month [based on 2011
specimen volume]) using Form 2:
Antimicrobial Susceptibility Testing.
For Form 2: Antimicrobial
Susceptibility Testing, the annual
frequency of responses per respondent
is 1,452 (121 isolates × 12 months).
Based on previous laboratory
experience, the estimated burden of
completing Form 2 for each
participating laboratory is 1 hour per
response, which includes the time
required for laboratory processing of the
patient’s isolate, gathering and
maintaining the data needed, and
completing and reviewing the collection
of information. For Form 3: Control
Strain Susceptibility Testing, a
‘‘response’’ is defined as the processing
and recording of Regional laboratory
data for a set of seven control strains. It
takes approximately 12 minutes to
process and record the Regional
laboratory data on Form 3 for one set of
seven control strains, of which there are
4 sets. The number of responses per
respondent is 48 (4 sets × 12 months).
There are no additional costs to
respondents. The total estimated annual
burden hours are 8,628.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Clinic .......................................
Laboratory ...............................
Demographic Clinical Data Form 1 ........................................
Antimicrobial Susceptibility Testing Form 2 ...........................
Control Strain Susceptibility Testing Form 3 .........................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–17263 Filed 7–17–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
TKELLEY on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:20 Jul 17, 2013
Jkt 229001
Comments on the collection(s) of
information must be received by the
OMB desk officer by August 19, 2013:
DATES:
[Document Identifier CMS–10062, CMS–
10146, CMS–10191, CMS–10308, CMS–R–43
and CMS–10453]
ACTION:
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–6974, or Email:
OIRA_submission@omb.eop.gov .
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
ADDRESSES:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
30
5
5
Number of
responses per
respondent
240
1,452
48
Average
burden per
response
(in hours)
11/60
1
12/60
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: Collection of
Diagnostic Data from Medicare
Advantage Organizations for Risk
SUPPLEMENTARY INFORMATION:
E:\FR\FM\18JYN1.SGM
18JYN1
TKELLEY on DSK3SPTVN1PROD with NOTICES
42958
Federal Register / Vol. 78, No. 138 / Thursday, July 18, 2013 / Notices
Adjusted Payments; Use: In the
Balanced Budget Act of 1997 (BBA),
Congress created the Medicare+Choice
(M+C or Part C) program in order to
expand the types of private entities
eligible to contract with Medicare and to
address some perceived flaws in the
risk-contracting program. Congress
subsequently refined the M+C program
through the Balanced Budget
Refinement Act of 1999 (BBRA) and the
Medicare, Medicaid, and SCHIP
Benefits Improvement and Protection
Act of 2000 (BIPA). Most recently,
under the Medicare Prescription Drug
Benefit, Improvement and
Modernization Act of 2003 (MMA),
Congress restructured the M+C program
into the Medicare Advantage (MA)
program and added an outpatient
prescription drug benefit, Part D.
The BBA of 1997 and later legislation
required CMS to adjust per-beneficiary
capitation payments with a risk
adjustment methodology using
diagnoses to measure relative risk due to
health status instead of just
demographic characteristics such as age,
sex, and Medicaid eligibility. Risk
adjustment using diagnoses provides
more accurate payments for MA
organizations, with higher payments for
enrollees at risk for being sicker, and
lower payments for enrollees predicted
to be healthier.
The MMA also instituted a bidding
system in Parts C and D with a
significant role for risk adjustment.
Thus, independent of enrollment and
payment, risk adjustment now plays a
significant role simply because it is
central to the bidding process. Under
the MMA, risk adjustment is used to
standardize bids. Plans bid on the
average beneficiary, referred to as a
‘‘standardized’’ bid for a beneficiary
with a 1.0 risk score. This enables
comparison of Part C and D bids against
a baseline (average) standard, even
though every plan will have different
enrollee characteristics and benefit
packages and will therefore have
different costs.
Previously, we received PRA
clearance to collect inpatient and
outpatient data for Part C using the
CMS–HCC model. Currently, we are
seeking to renew that OMB approval
and also clearance for changes in data
collection in order to fulfill new
mandates under the MMA. Form
Number: CMS–10062 (OCN: 0938–
0838); Frequency: Quarterly; Affected
Public: Private Sector (business or other
for-profit and not-for-profit institutions);
Number of Respondents: 766; Total
Annual Responses: 830,000; Total
Annual Hours: 40,650; (For policy
questions regarding this collection
VerDate Mar<15>2010
17:20 Jul 17, 2013
Jkt 229001
contact Michael Massimini at 410–786–
1566.)
2. Type of Information Collection
Request: Revision of a currently
approved collection;
Title of Information Collection: Notice
of Denial of Medicare Prescription Drug
Coverage; Use: Section 1860D–4(g)(1) of
the Social Security Act, requires that
Part D plan sponsors who deny
prescription drug coverage must provide
a written notice of the denial to the
enrollee. The written notice must
include a statement, in understandable
language, of the reasons for the denial
and a description of the appeals process.
The Part D denial notice has been
revised for clarity and includes new
optional language for Part D plan
sponsors to use when explaining their
denial rationale. Specifically, we added
optional language in the denial rationale
section of the notice to allow plans to
populate text explaining that a drug
denied under Part D may be (or is)
covered under a different benefit, such
as Part B. The instructions have also
been changed to guide plans on when to
use this optional text. We solicit
feedback on this new addition as well
as other situations where another
benefit may cover a drug (i.e. employer
group benefits) and what changes to the
denial notice may be helpful in
addressing those situations. We also
seek comment regarding the potential
viability and usefulness of developing a
combined notice for Part C and Part D,
which would allow MA–PD plans that
deny a drug under Part D to
simultaneously issue an approval letter
under Part B. Form Number: CMS–
10146 (OCN: 0938–0976); Frequency:
Occasionally; Affected Public: Private
sector (business or other for-profits);
Number of Respondents: 596; Total
Annual Responses: 1,497,929; Total
Annual Hours: 374,482; (For policy
questions regarding this collection
contact Caroline Baker at 410–786–
0116.)
3. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: Medicare Parts
C and D Universal Audit Guide; Use:
Under the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 and implementing regulations
under 42 CFR parts 422 and 423,
Medicare Part D plan sponsors and
Medicare Advantage organizations are
required to comply with all Medicare
Parts C and D program requirements. In
2010 the explosive growth of these
sponsoring organizations forced us to
develop an audit strategy to ensure we
continue to obtain meaningful audit
results. As a result, our audit strategy
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
reflected a move to a more targeted,
data-driven and risk-based audit
approach that focused on high-risk areas
having the greatest potential for
beneficiary harm.
To accomplish this we have combined
all Part C and Part D audit elements into
one universal guide which will also
promote consistency, effectiveness and
reduce financial and time burdens for
both CMS and Medicare-contracting
entities. The combined Medicare Part C
& D Universal Audit Guide received
OMB approval in 2010. The Health Plan
Management System (HPMS) is the
current conduit by which organizations
submit many sources of audit materials
such as bids and other ongoing updates
to us. Please note the guide is very
comprehensive in that it describes all
areas that could be audited. Due to
limited resources, we are unable to
audit all areas for any particular
sponsor. Some areas could be monitored
by the account manager, etc. Other areas
could be the audited in the program
audits.
To maximize resources, we will focus
on assisting the industry to improve
their operations to ensure beneficiaries
receive access to care. We will
accomplish this by developing an
annual audit strategy which describes
how sponsors will be selected for audit
and the areas that will be audited. The
audit strategy will be shared with the
industry via the CMS Web site, HPMS
memo, the Part C & D user call, and
other conferences. Once the audit areas
are defined, we will design audit
protocols describing in detail the focus
of the audit, the data required for the
audit, etc. The Engagement Letter and
Protocols will be sent to all sponsors
selected for audit 4 weeks prior to
starting the audit. In addition, the
protocols will be released to the
industry at the beginning of each
calendar year via the same manner as
the audit strategy. To assist in
improving the audit process, we send
the plan sponsors a survey at the end of
each audit to complete in order to
obtain the sponsors feedback. The
sponsor is not required to complete the
survey. The supporting materials for
this information collection request have
been revised since the 60-day Federal
Register notice published on February
28, 2013 (78 FR 4412). Form Number:
CMS–10191 (OCN: 0938–1000);
Frequency: Yearly; Affected Public:
Private Sector (business or other forprofit and not-for-profit institutions);
Number of Respondents: 195; Total
Annual Responses: 195; Total Annual
Hours: 24,180. (For policy questions
regarding this collection contact Tracey
Roberts at 410–786–8643.)
E:\FR\FM\18JYN1.SGM
18JYN1
TKELLEY on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 138 / Thursday, July 18, 2013 / Notices
4. Type of Information Collection
Request: Revision of a currently
approved collection. Title of
Information Collection: Parts C and D
Complaints Resolution Performance
Measures. Use: We seek to conduct a
survey as part of the Part C and D
Complaints Resolution Performance
Measure project. The purpose of the
project is to develop and support
implementation of internal monitoring
tools for the Medicare Advantage (Part
C) and Prescription Drug (Part D)
program that represents, from the
beneficiary’s perspective, the way in
which plans handle complaints. The
data collection is necessary because a
survey is the only way to collect
information about the resolution process
from the beneficiary’s perspective.
Currently, there is no other data source
that collects such information for Part C
and Part D Medicare plans. Form
Number: CMS–10308 (OCN: 0938–
1107); Frequency: Yearly; Affected
Public: Individuals or households;
Number of Respondents: 18,210; Total
Annual Responses: 18,210; Total
Annual Hours: 3,035. (For policy
questions regarding this collection
contact Carolyn Scott at 410–786–1190.)
5. Type of Information Collection
Request: Reinstatement with change of a
currently approved collection; Title of
Information Collection: Conditions of
Coverage for Portable X-ray Suppliers
and Supporting Regulations; Use: The
requirements contained in this
information collection request are
classified as conditions of participation
or conditions for coverage. These
conditions are based on a provision
specified in law relating to diagnostic Xray tests ‘‘furnished in a place of
residence used as the patient’s home,’’
and are designed to ensure that each
supplier has a properly trained staff to
provide the appropriate type and level
of care, as well as, a safe physical
environment for patients. We use these
conditions to certify suppliers of
portable X-ray services wishing to
participate in the Medicare program.
This is standard medical practice and is
necessary in order to help to ensure the
well-being, safety and quality
professional medical treatment
accountability for each patient. Form
Number: CMS–R–43 (OCN: 0938–0338);
Frequency: Yearly; Affected Public:
Business or other for-profit and Not-forprofit institutions; Number of
Respondents: 578; Total Annual
Responses: 578; Total Annual Hours:
948. (For policy questions regarding this
collections contact Alesia Hovatter at
410–786–6861.)
6. Type of Information Collection
Request: New collection (Request for a
VerDate Mar<15>2010
17:20 Jul 17, 2013
Jkt 229001
new OMB control number); Title of
Information Collection: The Medicare
Advantage and Prescription Drug
Program: Part C Explanation of Benefits
CFR 422.111(b)(12); Use: We are
requesting OMB approval for the
information collection requirements
referenced in the April 15, 2011 final
rule revising the Medicare Advantage
(MA) and Part D programs for calendar
year 2012 (77 FR 21432–21577). The
rule revised the MA disclosure
requirements in 42 CFR 422.111(b) by
adding the authority for CMS to require
MA organizations to furnish a written
explanation of benefits directly to
enrollees, in a manner we specify and
in a form easily understandable to
enrollees, when benefits are provided
under Part 422. The collection
instrument that requires OMB approval
concerns the disclosure requirements in
paragraph 42 CFR 422.111(b)(12).
In order to provide all Medicare
Advantage enrollees with consistent,
clear, useful information about their
medical claims, we established a
requirement, in the April 2011 final
rule, that MA organizations furnish
directly to enrollees, in the manner
specified by CMS and in a form easily
understandable to such enrollees, a
written explanation of benefits, when
benefits are provided under Part 422.
We finalized this policy based on the
public comments and input we have
received from beneficiaries, advocacy
organizations, health plans and industry
organizations. This EOB will help
ensure that people in the Medicare
Advantage program receive clear, timely
information, as do people receiving the
Medicare MSN and the Part D EOB, so
that they may make confident, informed
decisions about their healthcare options.
We stated that we would develop a
model EOB for Part C benefits modeled
after the EOB currently required for Part
D enrollees at § 423.128(e). After
publication of the final rule in April
2011, we engaged MA organizations,
industry and advocacy groups and
beneficiaries in listening sessions to
gather ideas and feedback. We
developed models based on that input,
as well as the newly redesigned and
consumer tested Medicare Summary
Notice and the Part D EOB. We have
tested models through a small pilot
program with a volunteer MA
organization in CY 2012. In designing
our model EOB, we considered language
and design from Medicare MSN,
integration of Part C and Part D EOBs,
level of detail, and frequency of EOB
dissemination as part of this process.
We sought additional public
comments on the model EOBs that we
developed through a Health Plan
PO 00000
Frm 00032
Fmt 4703
Sfmt 9990
42959
Management System (HPMS) memo
release with a 30 day comment period.
Our goal was to implement a model Part
C EOB document in mid-year 2013
based on this process, and to require all
MA organizations to periodically send
an EOB to enrollees for Part C benefits
in future years. This customized
information would supplement general
plan information in the annual notice of
change (ANOC) and evidence of
coverage (EOC) documents as well as
enhance the currently available
information through tools such as
Medicare Options Compare (MOC) and
the Medicare Prescription Drug Plan
Finder (MPDPF), which provide general
information about plan costs. Based on
public comments we received on the
HPMS memo and November 26, 2012
Federal Register notice (77 FR 70445)
and the revisions we made to the initial
templates and guidance, we are
extending the timeline for
implementation to April, 2014. We
intend for the Part C EOB to provide
personal information to beneficiaries
that would help them understand their
current utilization, keep track of their
out-of-pocket expenses, and to consider
using other tools and resources,
including MOC and MPDPF, to
determine whether to select a new plan.
As a result of comments received
during the 60-day comment period
associated with the November 26, 2012,
Federal Register notice (77 FR 70445),
we revised the collection request.
Specifically, we shortened the templates
by removing two sections. One section
was deemed to include information that
was not needed and information from
the second section was incorporated
into other sections. We clarified and
streamlined the presentation of the
information and modified some of the
language to be more beneficiaryfriendly. Form Number: CMS–10453
(OCN: 0938-New); Frequency: On
occasion; Affected Public: Private
Sector—Business or other for-profits;
Number of Respondents: 564; Number
of Responses: 2,256; Total Annual
Hours: 101,520. (For policy questions
regarding this collection contact Chris
McClintick at 410–786–4682.)
Dated: July 15, 2013.
Martique Jones,
Deputy Director, Regulations Development
Group, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2013–17317 Filed 7–17–13; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\18JYN1.SGM
18JYN1
Agencies
[Federal Register Volume 78, Number 138 (Thursday, July 18, 2013)]
[Notices]
[Pages 42957-42959]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-17317]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier CMS-10062, CMS-10146, CMS-10191, CMS-10308, CMS-R-
43 and CMS-10453]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of
information, including each proposed extension or reinstatement of an
existing collection of information, and to allow a second opportunity
for public comment on the notice. Interested persons are invited to
send comments regarding the burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
DATES: Comments on the collection(s) of information must be received by
the OMB desk officer by August 19, 2013:
ADDRESSES: When commenting on the proposed information collections,
please reference the document identifier or OMB control number. To be
assured consideration, comments and recommendations must be received by
the OMB desk officer via one of the following transmissions: OMB,
Office of Information and Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395-6974, or Email: OIRA_submission@omb.eop.gov .
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' Web site address at https://www.cms.hhs.gov/PaperworkReductionActof1995.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: Reports Clearance Office at (410) 786-
1326
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. The term ``collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
federal agencies to publish a 30-day notice in the Federal Register
concerning each proposed collection of information, including each
proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice that
summarizes the following proposed collection(s) of information for
public comment:
1. Type of Information Collection Request: Reinstatement with
change of a previously approved collection; Title of Information
Collection: Collection of Diagnostic Data from Medicare Advantage
Organizations for Risk
[[Page 42958]]
Adjusted Payments; Use: In the Balanced Budget Act of 1997 (BBA),
Congress created the Medicare+Choice (M+C or Part C) program in order
to expand the types of private entities eligible to contract with
Medicare and to address some perceived flaws in the risk-contracting
program. Congress subsequently refined the M+C program through the
Balanced Budget Refinement Act of 1999 (BBRA) and the Medicare,
Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000
(BIPA). Most recently, under the Medicare Prescription Drug Benefit,
Improvement and Modernization Act of 2003 (MMA), Congress restructured
the M+C program into the Medicare Advantage (MA) program and added an
outpatient prescription drug benefit, Part D.
The BBA of 1997 and later legislation required CMS to adjust per-
beneficiary capitation payments with a risk adjustment methodology
using diagnoses to measure relative risk due to health status instead
of just demographic characteristics such as age, sex, and Medicaid
eligibility. Risk adjustment using diagnoses provides more accurate
payments for MA organizations, with higher payments for enrollees at
risk for being sicker, and lower payments for enrollees predicted to be
healthier.
The MMA also instituted a bidding system in Parts C and D with a
significant role for risk adjustment. Thus, independent of enrollment
and payment, risk adjustment now plays a significant role simply
because it is central to the bidding process. Under the MMA, risk
adjustment is used to standardize bids. Plans bid on the average
beneficiary, referred to as a ``standardized'' bid for a beneficiary
with a 1.0 risk score. This enables comparison of Part C and D bids
against a baseline (average) standard, even though every plan will have
different enrollee characteristics and benefit packages and will
therefore have different costs.
Previously, we received PRA clearance to collect inpatient and
outpatient data for Part C using the CMS-HCC model. Currently, we are
seeking to renew that OMB approval and also clearance for changes in
data collection in order to fulfill new mandates under the MMA. Form
Number: CMS-10062 (OCN: 0938-0838); Frequency: Quarterly; Affected
Public: Private Sector (business or other for-profit and not-for-profit
institutions); Number of Respondents: 766; Total Annual Responses:
830,000; Total Annual Hours: 40,650; (For policy questions regarding
this collection contact Michael Massimini at 410-786-1566.)
2. Type of Information Collection Request: Revision of a currently
approved collection;
Title of Information Collection: Notice of Denial of Medicare
Prescription Drug Coverage; Use: Section 1860D-4(g)(1) of the Social
Security Act, requires that Part D plan sponsors who deny prescription
drug coverage must provide a written notice of the denial to the
enrollee. The written notice must include a statement, in
understandable language, of the reasons for the denial and a
description of the appeals process. The Part D denial notice has been
revised for clarity and includes new optional language for Part D plan
sponsors to use when explaining their denial rationale. Specifically,
we added optional language in the denial rationale section of the
notice to allow plans to populate text explaining that a drug denied
under Part D may be (or is) covered under a different benefit, such as
Part B. The instructions have also been changed to guide plans on when
to use this optional text. We solicit feedback on this new addition as
well as other situations where another benefit may cover a drug (i.e.
employer group benefits) and what changes to the denial notice may be
helpful in addressing those situations. We also seek comment regarding
the potential viability and usefulness of developing a combined notice
for Part C and Part D, which would allow MA-PD plans that deny a drug
under Part D to simultaneously issue an approval letter under Part B.
Form Number: CMS-10146 (OCN: 0938-0976); Frequency: Occasionally;
Affected Public: Private sector (business or other for-profits); Number
of Respondents: 596; Total Annual Responses: 1,497,929; Total Annual
Hours: 374,482; (For policy questions regarding this collection contact
Caroline Baker at 410-786-0116.)
3. Type of Information Collection Request: Reinstatement with
change of a previously approved collection; Title of Information
Collection: Medicare Parts C and D Universal Audit Guide; Use: Under
the Medicare Prescription Drug, Improvement, and Modernization Act of
2003 and implementing regulations under 42 CFR parts 422 and 423,
Medicare Part D plan sponsors and Medicare Advantage organizations are
required to comply with all Medicare Parts C and D program
requirements. In 2010 the explosive growth of these sponsoring
organizations forced us to develop an audit strategy to ensure we
continue to obtain meaningful audit results. As a result, our audit
strategy reflected a move to a more targeted, data-driven and risk-
based audit approach that focused on high-risk areas having the
greatest potential for beneficiary harm.
To accomplish this we have combined all Part C and Part D audit
elements into one universal guide which will also promote consistency,
effectiveness and reduce financial and time burdens for both CMS and
Medicare-contracting entities. The combined Medicare Part C & D
Universal Audit Guide received OMB approval in 2010. The Health Plan
Management System (HPMS) is the current conduit by which organizations
submit many sources of audit materials such as bids and other ongoing
updates to us. Please note the guide is very comprehensive in that it
describes all areas that could be audited. Due to limited resources, we
are unable to audit all areas for any particular sponsor. Some areas
could be monitored by the account manager, etc. Other areas could be
the audited in the program audits.
To maximize resources, we will focus on assisting the industry to
improve their operations to ensure beneficiaries receive access to
care. We will accomplish this by developing an annual audit strategy
which describes how sponsors will be selected for audit and the areas
that will be audited. The audit strategy will be shared with the
industry via the CMS Web site, HPMS memo, the Part C & D user call, and
other conferences. Once the audit areas are defined, we will design
audit protocols describing in detail the focus of the audit, the data
required for the audit, etc. The Engagement Letter and Protocols will
be sent to all sponsors selected for audit 4 weeks prior to starting
the audit. In addition, the protocols will be released to the industry
at the beginning of each calendar year via the same manner as the audit
strategy. To assist in improving the audit process, we send the plan
sponsors a survey at the end of each audit to complete in order to
obtain the sponsors feedback. The sponsor is not required to complete
the survey. The supporting materials for this information collection
request have been revised since the 60-day Federal Register notice
published on February 28, 2013 (78 FR 4412). Form Number: CMS-10191
(OCN: 0938-1000); Frequency: Yearly; Affected Public: Private Sector
(business or other for-profit and not-for-profit institutions); Number
of Respondents: 195; Total Annual Responses: 195; Total Annual Hours:
24,180. (For policy questions regarding this collection contact Tracey
Roberts at 410-786-8643.)
[[Page 42959]]
4. Type of Information Collection Request: Revision of a currently
approved collection. Title of Information Collection: Parts C and D
Complaints Resolution Performance Measures. Use: We seek to conduct a
survey as part of the Part C and D Complaints Resolution Performance
Measure project. The purpose of the project is to develop and support
implementation of internal monitoring tools for the Medicare Advantage
(Part C) and Prescription Drug (Part D) program that represents, from
the beneficiary's perspective, the way in which plans handle
complaints. The data collection is necessary because a survey is the
only way to collect information about the resolution process from the
beneficiary's perspective. Currently, there is no other data source
that collects such information for Part C and Part D Medicare plans.
Form Number: CMS-10308 (OCN: 0938-1107); Frequency: Yearly; Affected
Public: Individuals or households; Number of Respondents: 18,210; Total
Annual Responses: 18,210; Total Annual Hours: 3,035. (For policy
questions regarding this collection contact Carolyn Scott at 410-786-
1190.)
5. Type of Information Collection Request: Reinstatement with
change of a currently approved collection; Title of Information
Collection: Conditions of Coverage for Portable X-ray Suppliers and
Supporting Regulations; Use: The requirements contained in this
information collection request are classified as conditions of
participation or conditions for coverage. These conditions are based on
a provision specified in law relating to diagnostic X-ray tests
``furnished in a place of residence used as the patient's home,'' and
are designed to ensure that each supplier has a properly trained staff
to provide the appropriate type and level of care, as well as, a safe
physical environment for patients. We use these conditions to certify
suppliers of portable X-ray services wishing to participate in the
Medicare program. This is standard medical practice and is necessary in
order to help to ensure the well-being, safety and quality professional
medical treatment accountability for each patient. Form Number: CMS-R-
43 (OCN: 0938-0338); Frequency: Yearly; Affected Public: Business or
other for-profit and Not-for-profit institutions; Number of
Respondents: 578; Total Annual Responses: 578; Total Annual Hours: 948.
(For policy questions regarding this collections contact Alesia
Hovatter at 410-786-6861.)
6. Type of Information Collection Request: New collection (Request
for a new OMB control number); Title of Information Collection: The
Medicare Advantage and Prescription Drug Program: Part C Explanation of
Benefits CFR 422.111(b)(12); Use: We are requesting OMB approval for
the information collection requirements referenced in the April 15,
2011 final rule revising the Medicare Advantage (MA) and Part D
programs for calendar year 2012 (77 FR 21432-21577). The rule revised
the MA disclosure requirements in 42 CFR 422.111(b) by adding the
authority for CMS to require MA organizations to furnish a written
explanation of benefits directly to enrollees, in a manner we specify
and in a form easily understandable to enrollees, when benefits are
provided under Part 422. The collection instrument that requires OMB
approval concerns the disclosure requirements in paragraph 42 CFR
422.111(b)(12).
In order to provide all Medicare Advantage enrollees with
consistent, clear, useful information about their medical claims, we
established a requirement, in the April 2011 final rule, that MA
organizations furnish directly to enrollees, in the manner specified by
CMS and in a form easily understandable to such enrollees, a written
explanation of benefits, when benefits are provided under Part 422. We
finalized this policy based on the public comments and input we have
received from beneficiaries, advocacy organizations, health plans and
industry organizations. This EOB will help ensure that people in the
Medicare Advantage program receive clear, timely information, as do
people receiving the Medicare MSN and the Part D EOB, so that they may
make confident, informed decisions about their healthcare options.
We stated that we would develop a model EOB for Part C benefits
modeled after the EOB currently required for Part D enrollees at Sec.
423.128(e). After publication of the final rule in April 2011, we
engaged MA organizations, industry and advocacy groups and
beneficiaries in listening sessions to gather ideas and feedback. We
developed models based on that input, as well as the newly redesigned
and consumer tested Medicare Summary Notice and the Part D EOB. We have
tested models through a small pilot program with a volunteer MA
organization in CY 2012. In designing our model EOB, we considered
language and design from Medicare MSN, integration of Part C and Part D
EOBs, level of detail, and frequency of EOB dissemination as part of
this process.
We sought additional public comments on the model EOBs that we
developed through a Health Plan Management System (HPMS) memo release
with a 30 day comment period. Our goal was to implement a model Part C
EOB document in mid-year 2013 based on this process, and to require all
MA organizations to periodically send an EOB to enrollees for Part C
benefits in future years. This customized information would supplement
general plan information in the annual notice of change (ANOC) and
evidence of coverage (EOC) documents as well as enhance the currently
available information through tools such as Medicare Options Compare
(MOC) and the Medicare Prescription Drug Plan Finder (MPDPF), which
provide general information about plan costs. Based on public comments
we received on the HPMS memo and November 26, 2012 Federal Register
notice (77 FR 70445) and the revisions we made to the initial templates
and guidance, we are extending the timeline for implementation to
April, 2014. We intend for the Part C EOB to provide personal
information to beneficiaries that would help them understand their
current utilization, keep track of their out-of-pocket expenses, and to
consider using other tools and resources, including MOC and MPDPF, to
determine whether to select a new plan.
As a result of comments received during the 60-day comment period
associated with the November 26, 2012, Federal Register notice (77 FR
70445), we revised the collection request. Specifically, we shortened
the templates by removing two sections. One section was deemed to
include information that was not needed and information from the second
section was incorporated into other sections. We clarified and
streamlined the presentation of the information and modified some of
the language to be more beneficiary-friendly. Form Number: CMS-10453
(OCN: 0938-New); Frequency: On occasion; Affected Public: Private
Sector--Business or other for-profits; Number of Respondents: 564;
Number of Responses: 2,256; Total Annual Hours: 101,520. (For policy
questions regarding this collection contact Chris McClintick at 410-
786-4682.)
Dated: July 15, 2013.
Martique Jones,
Deputy Director, Regulations Development Group, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2013-17317 Filed 7-17-13; 8:45 am]
BILLING CODE 4120-01-P